IPM Take
This is the featured AI & Tech story because it moves the debate from hype to clinical power. AI is no longer only passing medical exams or summarising guidelines. In this study, it handled messy clinical reasoning tasks and real emergency department records well enough to outperform physicians in several comparisons. That is politically explosive, but it is not a licence to replace doctors. It is a warning that health systems now need real governance: prospective trials, liability rules, workflow integration, patient consent, bias monitoring and clarity on who is accountable when AI influences diagnosis.
Executive Summary
On 30 April 2026, a Harvard Medical School and Beth Israel Deaconess Medical Center team published a study in Science evaluating a large language model on clinical reasoning tasks normally performed by physicians. The study tested the model across diagnostic challenges, clinical reasoning exercises and real emergency department cases drawn from electronic health records. The institutional release states that the model outperformed physicians across many common clinical reasoning tasks, including emergency room decisions, identifying likely diagnoses and choosing next steps in management. In the real emergency department cases, the model was tested using information available at different points in care, from early triage to later admission decisions. The researchers stressed that the findings do not mean AI is ready to practice medicine autonomously, but they argue that medical AI is now ready for serious prospective clinical testing.
Why it matters
- Clinicians: Need to prepare for AI systems that may become second-opinion tools in diagnosis, triage and management, while keeping human responsibility clear.
- Hospitals / providers: Must decide how to validate, integrate and monitor AI tools inside real workflows before they affect patient decisions.
- Regulators / public authorities: Need prospective evidence standards, safety monitoring, liability frameworks and rules for when AI-supported diagnosis becomes clinical use.
- Patients / advocates: Should demand transparency when AI influences diagnosis, referral, triage or care decisions.
Previously, medical AI was often judged through exams, multiple-choice benchmarks or curated clinical vignettes. Those tests were useful, but they did not fully reflect the messy reality of care: incomplete records, time pressure, uncertainty and decisions made before all information is available.
What changed here is the level of clinical realism. The Harvard-led study tested a large language model not only on traditional diagnostic challenges, but also on real emergency department cases from electronic health records. The model was asked to reason with the information available at different points in the patient journey, including early triage, when data are sparse and decisions can shape the entire pathway.
That is why this article belongs as the main AI & Tech feature. The issue is not simply that AI performed well. The issue is that AI is now approaching the kind of reasoning that directly affects access: who gets escalated, who is referred, who is tested, who is reassured and who may be missed.
But the study also exposes the danger of overinterpretation. Retrospective performance is not the same as safe deployment. A model may identify the right diagnosis and still recommend unnecessary tests, miss contextual information, fail in underrepresented populations or create new liability problems. The researchers themselves argue that AI systems should now be tested like medical interventions, through rigorous clinical trials in real care settings.
For IPM, the message is sharp: clinical AI is entering the access debate before health systems are fully ready. If governed well, it could reduce missed diagnoses, support overstretched clinicians and help patients reach the right pathway earlier. If adopted carelessly, it could automate inequality, blur accountability and introduce unsafe shortcuts into clinical decision-making. The next phase of AI in medicine is not about whether the model is impressive. It is about whether the system around it is ready.
